If more time was spent on things that make life more high quality, less time would be spent on worrying about healthcare, said Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University.
If more time was spent on things that make life more high quality, less time would be spent on worrying about healthcare, said Sara Rosenbaum, JD, the Harold and Jane Hirsh Professor of Health Law and Policy and founding chair of the Department of Health Policy at the Milken Institute School of Public Health, George Washington University.
Transcript
How can health disparities be addressed in health policy?
Of course, health disparities are just an enormous issue. It begins with terrible disparities by race, by income, by other measures unrelated to the need for healthcare and overall health status. I was recently at Governor Ralph Northam’s inauguration, and he made the point that people who live in central city Richmond, Virginia, had a lifespan that was 10 years shorter than people who lived 2 miles from the capital in one of the Richmond suburbs.
If you look at the factors that cause those disparities, they really have less to do with healthcare, per say, but healthcare becomes one of the great moments in time when we come face to face with the effects of those disparities both because people are likely to receive less care and less high-quality care, but more importantly, because they arrive at the healthcare system so much sicker. A disparities agenda in health policy means that those of us like me who are insurance lawyers spend a lot of their time worrying about housing, and food deserts, and the quality of child care, access to parks, things that make life really not just more high quality but really are the building blocks of daily life. I think if we spent more time on that, we’d find we have to spend less time worrying about healthcare.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen